Antioxidants
Antioxidant supplements like alpha-lipoic acid and NAC have a genuinely strong mechanistic story: they measurably lower oxidative stress markers in trials. Whether that translates into a meaningful clinical outcome for an otherwise healthy person is a separate, harder question, and the evidence for that second step is thinner than the biochemistry alone suggests.
4 products · sorted by evidence grade
Common questions
Which antioxidant supplement has the best evidence?
The strongest options in this category top out at grade B, and their evidence is condition-specific rather than a general "antioxidant boost." NAC (grade B) has decades of clinical use for liver protection and cutting exacerbations in chronic bronchitis and COPD; lutein & zeaxanthin (grade B) anchor the largest eye-health trial ever run (AREDS2) and earn a grade A for one narrow claim: safely replacing beta-carotene in AMD formulas for former smokers. Alpha-lipoic acid (grade B) has a real signal for diabetic nerve pain, though a 2024 Cochrane review found the oral form most people buy has much thinner support than the IV dosing behind the older headline trials. Astaxanthin is grade C overall: its skin-protection and exercise-recovery signals are promising (each graded B) but thin — the skin claim rests on a single 22-person trial and the exercise claim on a handful of small RCTs that don't all replicate — and its "longevity vitamin" fame rests entirely on mouse data.
Do antioxidant supplements actually work, or is it hype?
They reliably lower oxidative-stress markers in blood tests, but that biomarker change isn't the same as a proven health benefit, so the honest payoff is specific rather than general. NAC (grade B) has real evidence for liver and respiratory support, alpha-lipoic acid (grade B) for diabetic neuropathy symptoms, and lutein & zeaxanthin (grade B) for slowing AMD progression in people already at risk. Astaxanthin's most-marketed longevity claim is grade C and untested in humans, and alpha-lipoic acid was no better than placebo for blood sugar in the trials NCCIH reviewed. If you don't have the particular condition each one was studied for, the case for taking it as broad "antioxidant support" is weak.
When the evidence changes, we’ll tell you.
One short email a month. New A-grades, downgraded claims, and reader questions.
Medical disclaimer. The information on this site is provided for educational purposes only and is not intended as medical advice. It does not constitute a diagnosis, treatment plan, or recommendation for any specific health condition. Always consult a qualified healthcare professional before making changes to your supplement regimen, diet, or lifestyle — especially if you are pregnant, nursing, taking medications, or managing a medical condition.
Affiliate disclosure. Some links on this site are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. This never influences our editorial assessments — products are graded solely on the evidence.